June 15, 2023 03:18 PM EDT
Pharma
Marketing

No­vo Nordisk boosts an­ti-obe­si­ty stig­ma ef­forts with film and TV doc­u­men­tary part­ner­ships

Beth Snyder Bulik

Senior Editor

No­vo Nordisk is am­pli­fy­ing its ef­forts to dis­pel bias and stig­ma around obe­si­ty with two spon­sored doc­u­men­tary projects. The first is a fea­ture-length film and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times